BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,004 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,128,151 | +459.0% | 24,730 | +399.8% | 0.02% | +400.0% |
| Q1 2023 | $201,831 | -39.6% | 4,948 | -24.2% | 0.01% | -44.4% |
| Q4 2022 | $334,425 | -21.3% | 6,530 | -17.2% | 0.01% | -30.8% |
| Q3 2022 | $425,000 | -29.6% | 7,886 | -16.0% | 0.01% | -48.0% |
| Q2 2022 | $604,000 | -15.2% | 9,390 | +2.3% | 0.02% | +8.7% |
| Q1 2022 | $712,000 | +18.1% | 9,175 | +30.8% | 0.02% | +35.3% |
| Q4 2021 | $603,000 | +7.1% | 7,014 | +0.4% | 0.02% | -5.6% |
| Q3 2021 | $563,000 | +3.3% | 6,988 | +3.4% | 0.02% | 0.0% |
| Q2 2021 | $545,000 | -14.8% | 6,761 | -10.8% | 0.02% | -21.7% |
| Q1 2021 | $640,000 | +16.8% | 7,580 | +11.0% | 0.02% | -20.7% |
| Q4 2020 | $548,000 | +54.8% | 6,826 | +55.3% | 0.03% | +52.6% |
| Q3 2020 | $354,000 | -9.9% | 4,394 | -3.5% | 0.02% | -26.9% |
| Q2 2020 | $393,000 | +32.8% | 4,554 | +25.0% | 0.03% | +4.0% |
| Q1 2020 | $296,000 | +33.3% | 3,642 | +37.6% | 0.02% | +31.6% |
| Q4 2019 | $222,000 | -15.9% | 2,647 | -12.1% | 0.02% | -26.9% |
| Q3 2019 | $264,000 | -19.5% | 3,011 | -25.2% | 0.03% | -36.6% |
| Q1 2019 | $328,000 | +48.4% | 4,026 | +20.4% | 0.04% | +32.3% |
| Q4 2018 | $221,000 | -14.7% | 3,343 | +0.0% | 0.03% | 0.0% |
| Q3 2018 | $259,000 | +28.9% | 3,342 | -31.4% | 0.03% | -32.6% |
| Q1 2016 | $201,000 | +415.4% | 4,874 | +811.0% | 0.05% | +4500.0% |
| Q4 2014 | $39,000 | – | 535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
| NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
| Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
| Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
| GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
| Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
| Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
| Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
| Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |